Skip to main content
We use cookies to improve our service and to tailor our content and advertising to you.
More info
You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our
cookies policy
.
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
Archive
Volume 5, Issue 1
Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Responses
Article
metrics
Alerts
PDF
Clinical trials and drug discovery
Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus
Statistics from Altmetric.com
Online download statistics by month:
Online download statistics by month: April 2018 to August 2018
Abstract
Full
Pdf
Apr 2018
513
521
107
May 2018
402
418
111
Jun 2018
278
285
83
Jul 2018
244
244
70
Aug 2018
389
388
80
Total
1826
1856
451
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
